Archimedes Tech SPAC Partners III - Unit

ARCIU.US released FY2025 Annual Earnings on January 20 Post-Market (BJT), actual revenue USD 0, actual EPS USD -0.0333

XWELL

Braiin

Leverage Shares 2X Long CRCL Daily ETF

T-REX 2X Long UPXI Daily Target ETF

T-REX 2X Long CRCL Daily Target ETF

ProShares Ultra CRCL ETF

Larimar Therapeutics

Cardio Diagnostics

A SPAC III ACQUISITION CORP. COM NPV CL A (SUBS/RTS)02/01/2026

VS MEDIA

ARCIU

<p>Archimedes Tech SPAC Partners III Co. has successfully closed its upsized initial public offering, raising $276 million by issuing 27.6 million units at $10.00 each. The offering included 3.6 million units from the underwriters' over-allotment option. The units began trading on Nasdaq under the ticker symbol "ARCIU" on January 23, 2026. Each unit consists of one ordinary share and one-fourth of a redeemable warrant, with the whole warrant allowing purchase of an ordinary share at $11.50. The company aims to focus on technology sector acquisitions, particularly in AI, cloud services, and automotive technology.</p>

StockTitan

Archimedes Tech SPAC Partners III Co. Announces Closing of Upsized $276 Million Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option | ARCIU Stock News

Archimedes Tech SPAC Partners III - Unit(ARCIU.US)

Archimedes Tech SPAC Partners III Co. Announces Closing of Upsized $276 Million Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option | ARCIU Stock News